The General Directorate of Medicines, Food, and Medical Devices (DIGEMAPS) took a decisive step toward harmonizing the regulatory standards applicable to medicines marketed in the Dominican Republic. Through Resolution DG-0003-2026, signed on June 2, the health authority establishes a uniform mechanism for verifying compliance with Good Manufacturing Practices (GMP) for medicines manufactured abroad and, most importantly, sets the dates from which such compliance will be mandatory. Although the resolution represents

For years, the global economy has undergone a process of technological evolution and accelerated growth in innovation.